Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

Author:  ["Orit Kollet","Ayelet Dar","Shoham Shivtiel","Alexander Kalinkovich","Kfir Lapid","Yejezkel Sztainberg","Melania Tesio","Robert M Samstein","Polina Goichberg","Asaf Spiegel","Ari Elson","Tsvee Lapidot"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Here we investigated the potential role of bone-resorbing osteoclasts in homeostasis and stress-induced mobilization of hematopoietic progenitors. Different stress situations induced activity of osteoclasts (OCLs) along the stem cell–rich endosteum region of bone, secretion of proteolytic enzymes and mobilization of progenitors. Specific stimulation of OCLs with RANKL recruited mainly immature progenitors to the circulation in a CXCR4- and MMP-9–dependent manner; however, RANKL did not induce mobilization in young female PTPε-knockout mice with defective OCL bone adhesion and resorption. Inhibition of OCLs with calcitonin reduced progenitor egress in homeostasis, G-CSF mobilization and stress situations. RANKL-stimulated bone-resorbing OCLs also reduced the stem cell niche components SDF-1, stem cell factor (SCF) and osteopontin along the endosteum, which was associated with progenitor mobilization. Finally, the major bone-resorbing proteinase, cathepsin K, also cleaved SDF-1 and SCF. Our findings indicate involvement of OCLs in selective progenitor recruitment as part of homeostasis and host defense, linking bone remodeling with regulation of hematopoiesis.

Cite this article

Kollet, O., Dar, A., Shivtiel, S. et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12, 657–664 (2006). https://doi.org/10.1038/nm1417

View full text

>> Full Text:   Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis